MCMCB Pro
C69.41

C69.41Malignant neoplasm of right ciliary body

Billable / specific codeICD-10-CMright

C69.41 is a billable, specific ICD-10-CM code for malignant neoplasm of right ciliary body. It is valid for submission on a claim.

Risk adjustment

C69.41 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

  • HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C69.41 is named in 78 Medicare coverage policies 78 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

  • A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
  • A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
  • A52479Oral Anticancer Drugs - Policy Article
  • A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article

Related codes at this level

Codes that share C69.4. If C69.41 is not quite right, the correct code is usually one of these.

Questions about C69.41

Is C69.41 a billable ICD-10-CM code?
Yes. C69.41 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C69.41 sit in the tabular list?
Neoplasms (C00-D49), in the block Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72).
ICD-10-CMFY2026-Apr· effective April 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release — see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.